24/7 LIVE STAFF — Compassionate help, any time day or night
CALL NOW 1-888-ATTY-911
Blog |

City of Southlake Defective Breast Mesh & Implant Injury Attorneys: Attorney911 Litigates Allergan BIOCELL (Recalled July 2019), Mentor MemoryGel and Sientra OPUS Failures Under Riegel Parallel-Claim Doctrine and 21 CFR Parts 803, 807 & 814 — Ralph Manginello’s 27+ Years of Federal Trial Experience and Lupe Peña’s Former-Insurance-Defense Insight for North Texas Patients — We Pursue Claims for BIA-ALCL (CD30+/ALK-), BIA-SCC, AlloDerm and Strattice ADM Complications and GalaFLEX P4HB Scaffold Failures — MDL 2921 Before Judge Martinotti (Bellwether October 19, 2026) — Texas 2-Year Statute (CPRC § 16.003) and Discovery Rule — $50M+ Recovered and Active $10M Bermudez Litigation — Hablamos Español: Lupe Peña Conducts Full Spanish Consultations — Free 24/7 Consultation — No Fee Unless We Recover Compensation for You — 1-888-ATTY-911

May 14, 2026 16 min read
city-of-southlake-featured-image.png

Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in Southlake: The Definitive Guide for Women, Families, and Survivors

When you chose to undergo breast surgery—whether it was a life-saving reconstruction following a mastectomy, a prophylactic procedure due to a BRCA mutation, or a cosmetic augmentation to restore your confidence—you placed your trust in the medical device industry. You trusted that the materials implanted in your body, from acellular dermal matrices (ADMs) used as “internal bras” to bioabsorbable scaffolds like GalaFLEX, were rigorously tested and proven safe for use in human breast tissue.

Today, many women in Southlake and throughout Tarrant County are discovering that this trust may have been misplaced. We are hearing from survivors who are facing devastating complications: chronic infections, reconstruction failures, disfigurement, and rare cancers like BIA-ALCL. At The Manginello Law Firm, PLLC, operating under our consumer brand Attorney911, we know that these injuries are not just “unfortunate side effects.” Often, they are the result of a regulatory system that allowed devices onto the market without ever being specifically cleared by the FDA for breast surgery.

If you are a resident of Southlake, Westlake, or the surrounding DFW Metroplex dealing with the fallout of a defective medical device, you need more than just a lawyer. You need a team that understands the microscopic science of endotoxin-mediated inflammation and the complex legal doctrines of federal preemption. We are here to provide that depth. Our managing partner, Ralph Manginello, has spent twenty-seven years fighting for the catastrophically injured, and our associate Lupe Peña brings a unique perspective from the world of insurance defense to our firm’s strategic arsenal.

If you have questions about your health and your legal rights, we invite you to call us at 1-888-ATTY-911 for a confidential, no-obligation consultation. Whether you were treated at a major medical center in the DFW corridor or a private surgical practice near Southlake Town Square, your voice deserves to be heard.

Understanding the Hidden Crisis in Breast Surgery Devices

For many patients in Southlake, the terminology used in surgical consultations can be confusing. When surgeons mention “mesh” or “scaffolds,” they are often referring to products categorized as either biologic or synthetic. Acellular Dermal Matrix (ADM) is a biologic material, typically derived from human or animal skin, that has been processed to remove all cells while keeping the underlying structure intact. Bioabsorbable scaffolds, like GalaFLEX or Phasix, are synthetic materials designed to provide temporary support before being absorbed by your body.

The “internal bra” technique has become increasingly popular in Southlake cosmetic and reconstructive practices. This involves using these mesh or scaffold products to support the lower part of the breast, much like a traditional bra, to prevent sagging or to hold an implant in place. However, what many patients were never told is that the FDA has never determined that surgical mesh is safe or effective for use in breast surgery.

The products currently under scrutiny include well-known brands such as:

  • AlloDerm and Strattice (Allergan / AbbVie)
  • GalaFLEX and GalaFLEX 3D (Becton Dickinson / Galatea Surgical)
  • FlexHD and DermaMatrix (MTF Biologics)
  • Phasix Mesh (Becton Dickinson / C.R. Bard)
  • AlloMax (C.R. Bard / Becton Dickinson)
  • DuraSorb (Integra LifeSciences)

Managing Partner Ralph Manginello has navigated the complexities of corporate liability for nearly three decades, and we believe the manufacturers of these devices must be held accountable for marketing them for uses the FDA never explicitly authorized. When you call 1-888-ATTY-911, we look at the specific lot numbers and device identifiers unique to your surgery to build a case centered on the truth of what happened in the operating room.

The 510(k) Pathway and the Problem of “Predicate Creep”

How did so many devices end up in the bodies of women in Southlake if they weren’t approved for breast surgery? The answer lies in the FDA’s 510(k) clearance pathway. Unlike the rigorous Premarket Approval (PMA) process required for some high-risk devices, the 510(k) pathway allows a manufacturer to bring a product to market simply by showing it is “substantially equivalent” to a previous “predicate” device.

This has led to a phenomenon known as “predicate creep.” For example, the manufacturer of GalaFLEX surgical mesh cited a surgical suture as one of its predicate devices. By claiming that a mesh is essentially the same as a suture, manufacturers bypassed the need for new, long-term clinical trials in breast tissue. This is a critical distinction that Ralph Manginello and our team use to overcome defense arguments. Because these devices were cleared via 510(k) rather than PMA, they generally do not benefit from the same federal preemption protections established in Riegel v. Medtronic. Under Medtronic v. Lohr, 518 U.S. 470 (1996), state-law product liability claims against 510(k)-cleared devices are usually permitted to move forward.

Our associate, Lupe Peña, provides an invaluable advantage here. Having worked in insurance defense, Lupe Peña knows exactly how manufacturers try to hide behind these regulatory loopholes. We use that “insider” knowledge to pierce the corporate shield. If you are a Southlake resident whose surgeon used a device that was “cleared” but never “approved” for your specific procedure, the legal ground may be firmer than you realize.

Verbatim FDA Warnings Every Southlake Patient Should See

We believe in radical transparency. It is important for survivors in Southlake to read exactly what the federal regulators have said about these products. In a landmark letter to healthcare providers on November 9, 2023, the FDA stated:

“The safety and effectiveness of surgical mesh in breast surgery, including in augmentation or reconstruction, has not been determined by the FDA.”

The same letter identified Becton Dickinson (BD) products like GalaFLEX Scaffold, GalaFLEX 3D, and Phasix Mesh as part of a labeling update that explicitly warned that their safety in breast surgery was unproven. Furthermore, as early as March 31, 2021, the FDA warned that certain ADMs like FlexHD and AlloMax were associated with significantly higher rates of reoperation and infection compared to other products.

If you underwent surgery at a Tarrant County facility and are now experiencing complications, these FDA statements are Tier-1 evidence. Ralph Manginello and the team at Attorney911 are currently evaluating cases where these warnings were ignored or where the manufacturer’s off-label promotion outweighed the surgeon’s duty to inform the patient of the risks.

The Complication Spectrum: From Chronic Pain to BIA-ALCL

The injuries associated with defective breast mesh and scaffolds are often life-altering. For some women in Southlake, the signs appear within weeks of surgery. For others, the most dangerous complications—including cancer—settle in years later.

Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

BIA-ALCL is a rare T-cell lymphoma that develops in the capsule around the implant. It is most strongly associated with textured surfaces, such as those found in the recalled Allergan BIOCELL implants. The pathology is highly specific: it is typically CD30-positive and ALK-negative. If you have been diagnosed with BIA-ALCL, we provide the aggressive advocacy needed to navigate the consolidated litigation currently moving through federal court.

Breast Implant-Associated Squamous Cell Carcinoma (BIA-SCC)

In September 2022, the FDA issued a safety communication regarding BIA-SCC, a distinct epithelial tumor identified in implant capsules. Unlike ALCL, this cancer has been found with both textured and smooth implants, and it often has an extremely long latency period, sometimes appearing up to 42 years post-implantation.

Red Breast Syndrome and Endotoxin Toxicity

Many ADM patients experience “Red Breast Syndrome,” a persistent, non-infectious redness that looks like an infection but doesn’t respond to antibiotics. Peer-reviewed research, including work by Nguyen et al., suggests this is a reaction to bacterial endotoxins that remain on the ADM even after it is sterilized. Because endotoxins are not inactivated by standard sterilization, they can trigger a powerful inflammatory response in the patient.

Reconstruction Failure and Disfigurement

When a mesh or scaffold fails, it often leads to “bottoming out,” migration, or the total loss of the reconstruction. For many Southlake breast cancer survivors, this means undergoing five, six, or even ten revision surgeries. The emotional and financial toll of these failures is precisely why we pursue maximum compensation for our clients.

Lupe Peña and Ralph Manginello are prepared to handle the most complex medical evidence, ensuring that the true cause of your injury is brought to light. If you are suffering and unsure where to turn, Southlake residents are encouraged to reach out to us at 888-288-9911 for clear answers.

Why Experience in Institutional Liability Matters

Medical device litigation is a fight against some of the largest corporations in the world. To win, you need a firm with a record of taking on massive organizations. We are currently lead counsel in Bermudez v. Pi Kappa Phi, a high-profile case involving thirteen defendants, including a major university system. This litigation, which sought $10,000,000 in damages and resulted in the closure of a campus chapter, demonstrates our ability to manejer multi-defendant, high-stakes institutional liability cases.

This is the same level of intensity we bring to defective breast mesh cases. Ralph Manginello and Lupe Peña are lawyers who do not back down when faced with corporate defense teams. Whether it’s a hazing death or a defective bioabsorbable scaffold, the principles are the same: corporate entities must be held accountable when their pursuit of revenue comes at the cost of human life and safety.

Independent ratings verify this commitment. Ralph Manginello holds an Avvo Rating of 8.2 “Excellent” and has a 5.0 out of 5.0 client review score across 22 verified reviews. We are also proud members of the Pasadena Chamber of Commerce and have maintained a strong presence in the State Bar of Texas Pro Bono College, which recognizes attorneys who go far beyond the call of duty for their communities.

The Whistleblower: Dr. Hooman Noorchashm’s Record

Every woman in Southlake whose surgeon used GalaFLEX should know the name Dr. Hooman Noorchashm. A cardiothoracic surgeon and former Medical Director at Becton Dickinson, Dr. Noorchashm became a whistleblower in 2022. He alleged that BD withheld data concerning breast cancer recurrences in its GalaFLEX clinical trials and engaged in widespread off-label marketing.

Dr. Noorchashm filed formal citizen petitions with the FDA, warning that the malpractice liability for the non-standard use of GalaFLEX was being shifted onto surgeons while the manufacturer reaped the profits. His record is a key part of our investigative strategy. We look at the “Manufacturer and User Facility Device Experience” (MAUDE) database to find the red flags the company may have tried to minimize.

Texas Laws and the Discovery Rule in Tarrant County

When you are considering a lawsuit in Southlake, time is your most critical factor. Texas generally applies a two-year statute of limitations for personal injury and product liability claims. However, because many mesh complications take years to develop, the “discovery rule” is vital. This rule may allow the clock to start only when you realized—or should have realized—that your injury was caused by the defective medical device.

Tarrant County victims must also consider the Northern District of Texas when cases move to federal court. Ralph Manginello’s twenty-seven years of practice and admission to federal courts throughout the state ensure that your case is prepared for whatever venue it lands in.

We also understand the financial hurdles of litigation. The Manginello Law Firm, PLLC works on a contingency fee basis. This means we advance all the costs of the litigation, and we only get paid if we recover compensation for you. There are no upfront fees and no hourly bills to worry about while you are focused on your recovery.

Hablamos Español: Bilingual Advocacy for Southlake Families

Access to justice should never be limited by a language barrier. Our associate, Lupe Peña, conducts full client consultations in fluent Spanish. This is not a service where we use a translation line; it is direct, attorney-to-client communication. Many families in Southlake and the DFW area feel more comfortable discussing sensitive medical details and legal strategies in their primary language.

Si usted o un ser querido ha sido lesionado por una malla de seno o un andamio bioabsorbible defectuoso, Lupe Peña está aquí para escuchar su historia. Entendemos que estos casos son profundamente personales, y nuestra capacidad bilingüe asegura que nada se pierda en la traducción. Llámenos hoy al 1-888-ATTY-911 para una consulta gratuita y totalmente en español.

Managing the Path Ahead: Evidence and Documentation

If you believe you have a claim, the steps you take now in Southlake are essential. We recommend the following:

  1. Request Your Operative Reports: These will contain the “device implant stickers” or “Unique Device Identifiers” (UDIs) that tell us exactly what brand and lot number was used.
  2. Preserve the Explanted Device: If you are undergoing revision surgery, tell your surgeon and the hospital pathology department that you want the removed mesh or scaffold preserved for your legal team.
  3. Document Symptoms: Keep a journal of redness, pain, fluid drainage, and fever. Photographs are often the most powerful evidence we have.

We also encourage you to look at the larger body of our educational work. We host the Attorney911 Podcast, active with over 56 episodes on Apple Podcasts and Spotify, where Ralph Manginello discusses various aspects of the law. Education is the first step toward empowerment.

Frequently Asked Questions for Southlake Patients

Is surgical mesh actually approved for breast surgery?
No. As the FDA stated in November 2023, the safety and effectiveness of mesh in breast reconstruction or augmentation have not been determined. It is currently being used “off-label.”

What is the “internal bra” procedure?
In cosmetic surgery, surgeons often use a scaffold like GalaFLEX or ADM like AlloDerm to reinforce the breast tissue, helping to prevent sagging and providing the internal support a bra would provide. If this scaffold fails or causes an immune response, you may have a claim.

Will my health insurance cover the removal of these devices?
This is a complex issue. While the Women’s Health and Cancer Rights Act of 1998 requires plans to cover reconstruction after mastectomy, coverage for elective “explant” surgery varies. Lupe Peña’s background in insurance defense helps us navigate these coverage denials on behalf of our clients.

Who do I file the lawsuit against?
In most cases, the primary defendant is the manufacturer of the device (such as Becton Dickinson or Allergan). However, in some Tarrant County cases, there may be secondary claims regarding medical malpractice or hospital credentialing if the risks were not properly disclosed.

How long will my case take?
Individual cases vary, but mass-tort litigation often takes several years to reach a resolution. The Allergan BIOCELL MDL 2921 has its first bellwether trial scheduled for October 19, 2026. This trial will provide a major signal for how these cases will be valued moving forward.

Trusting a Firm with a Proven Legacy

At Attorney911, our goal is to restore the agency that was taken from you when you were implanted with a defective device. We have seen the incredible hundreds of reviews—a 4.9 out of 5.0-star rating across over 470 Birdeye reviews—that attest to our commitment to client satisfaction. Ralph Manginello’s recognition as a member of the Pro Bono College of the State Bar of Texas reflects a lifelong commitment to justice and helping those who cannot help themselves.

We are rooted in Texas. Ralph Manginello was raised in the Memorial area of Houston and has deep ties to the communities we serve. Our association with the Pasadena Chamber of Commerce and our statewide footprint mean we are your neighbors. We aren’t a national “settlement mill” that will treat you like a number. We are a family-oriented firm that treats every Southlake client with the same care we would give our own relatives.

Contact Attorney911 Today for Your Free Southlake Consultation

Do not let the statute of limitations close your window of opportunity. Every day you wait is a day that evidence can be lost or defense teams can prepare and build their narrative. We have the technical authority to challenge the manufacturers and the local presence to fight for you right here in Tarrant County.

Whether you are a breast cancer survivor at a facility near the Southlake Town Square or a cosmetic patient at a North Dallas surgery center, we want to help. Call 1-888-ATTY-911 (1-888-288-9911) right now. Our team, led by Ralph Manginello and Lupe Peña, is ready to start the investigation into the products used in your surgery.

Tu futuro y tu salud son nuestra prioridad. Llámenos al 1-888-ATTY-911. Hablamos español y estamos listos para representarle. Past results do not guarantee future outcomes, but our dedication to every client remains constant. No fee unless we recover compensation for you. Case expenses may apply.

We are here for Southlake. We are here for the survivors. We are here for you.

Key Resources and Verification Links

  • Firm Credentials: Ralph P. Manginello (Bar #24007597), Lupe E. Peña (Bar #24084332).
  • Case Reference: Bermudez v. Pi Kappa Phi, Harris County District Court, November 21, 2025.
  • FDA Primary Source: FDA Safety Communication on ADM, March 31, 2021; FDA BD Labeling Letter, November 9, 2023.
  • Multidistrict Litigation: In re Allergan BIOCELL Textured Breast Implant Products Liability Litigation, MDL No. 2921, District of New Jersey.
  • Whistleblower Info: Dr. Hooman Noorchashm’s documented CEPA filings in Bergen County, NJ.

If you have found yourself in a medical nightmare after trusting a surgical device, you do not have to walk that path alone. Contact Ralph Manginello and Lupe Peña today. Let our twenty-seven years of experience and our bilingual, client-centered approach work for you. Reach out to 1-888-ATTY-911 or visit our website to start your journey toward justice.

Share this article:

Need Legal Help?

Free consultation. No fee unless we win your case.

Call 1-888-ATTY-911

Ready to Fight for Your Rights?

Free consultation. No upfront costs. We don't get paid unless we win your case.

Call 1-888-ATTY-911